Target
Hepatocyte growth factor receptor [1038-1346]
Ligand
BDBM106388
Substrate
n/a
Meas. Tech.
c-Met In Vitro Kinase Assay
Temperature
303.15±n/a K
IC50
109±n/a nM
Comments
extracted
Citation
 Zhong, BShih, CYuan, HZhou, F Highly selective c-Met inhibitors as anticancer agents US Patent  US9695175 Publication Date 7/4/2017 
Target
Name:
Hepatocyte growth factor receptor [1038-1346]
Synonyms:
Hepatocyte growth factor receptor (MET) | MET | MET_HUMAN
Type:
n/a
Mol. Mass.:
34804.00
Organism:
Homo sapiens (Human)
Description:
c-Met kinase (1038-1346 aa)
Residue:
309
Sequence:
GDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG
  
Inhibitor
Name:
BDBM106388
Synonyms:
US9695175, 32
Type:
Small organic molecule
Emp. Form.:
C20H14F3N7
Mol. Mass.:
409.3673
SMILES:
Cc1cncc(c1)-c1ccc2nnc(n2n1)C(F)(F)c1cc2cn(C)nc2cc1F
Structure:
Search PDB for entries with ligand similarity: